Progression of diabetic nephropathy

American Journal of Kidney Diseases

Volumn 41, Issue 3 SUPPL. 1, 2003, Pages

  Kikkawa, Ryuichi ^a   Koya, Daisuke ^a   Haneda, Masakazu ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Diabetic nephropathy; Mechanical stretch; Mitogen activated protein kinase (MAPK); Protein kinase C (PKC); Protein kinase C (PKC) inhibitor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADVANCED GLYCATION END PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C BETA; PROTEIN KINASE C INHIBITOR;

ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; MESANGIUM CELL; METABOLIC ACTIVATION; OXIDATIVE STRESS; PROTEIN FAMILY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0037374252     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2003.50077     Document Type: Conference Paper

References (18)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
3. Ohkubo Y, Kishikawa H, Arald E, et al: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995
4. Lewis EJ, Hunsicker LG, Bain RP. Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl. J Med 329:1456-1462, 1993
5. Brenner BM, Cooper ME, de Zeeuw D, et al: RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
6. Lewis EJ, Hunsicker LG, Clarke WR, et al: Collaborative Study Group: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
7. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47:859-866, 1998
8. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R: Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46:847-853, 1997
9. Kikkawa R, Umemura K, Haneda M, Arimura T, Ebata K, Shigeta Y: Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes 36:240-243, 1987
10. Haneda M, Kikkawa R, Arimura T, et al: Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells. Metabolism 39:40-45, 1990
11. Suzuki D, Miyata T, Saotome N, et al: Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol 10:822-832, 1999
12. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
13. Isshiki K, Haneda M, Koya D, Maeda S, Sugimoto T, Kikkawa R: Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin sensitizing action in diabetic rats. Diabetes 49:1022-1032, 2000
14. Koya D, Haneda M, Nakagawa H, et al: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14:439-447, 2000
15. Koya D, Lee IK, Ishii H, Kanoh H, King GL: Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J Am Soc Nephrol 8:426-435, 1997
16. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL: Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β1, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
17. Ishida T, Haneda M, Maeda S, Koya D, Kikkawa R: Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase. Diabetes 48:595-602, 1999
18. Kikkawa R, Haneda M, Uzu T, Koya D, Sugimoto T, Shigeta Y: Translocation of protein kinase C α and ζ in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia 37:838-841, 1994